user-group INVESTOR ACCESS
  1. Home
  2. /
  3. Venture Capital
  4. /
  5. MRM Health Reports Preclinical...

Venture Capital

MRM Health Reports Preclinical Results Showing a 9-Strain Bacterial Consortium Delays Non-Alcoholic Fatty Liver Disease Progression and Liver Fibrosis

6 June 2022

Download

Press Release
Download

Related News

  • Venture Capital
  • Other news

Mérieux Equity Partners announces first closing of Mérieux Innovation 2 and first investment in deepull.

arrow-up-right
  • Buyout
  • Buyout

Mérieux Equity Partners sells minority stake in Ceva Santé Animale held by its fund Mérieux Participations 3, and reinvests in the company with Mérieux Participations 4

arrow-up-right
  • Buyout
  • Recent investments & divestments

Mérieux Equity Partners acquires a majority stake in Curea Medical

arrow-up-right
Lyon
Paris
Contact
  • ⓒ MERIEUX EQUITY PARTNERS 2023
  • Mérieux Equity Partners vehicles are only open to Professional Clients - as defined in the French Monetary code (CMF) and AMF regulation (RG).